4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like EnteroMedics Announces Proposed Underwritten Public Offering August 10, 2017 FDA Issues New Draft Guidance for Alzheimer’s Trials that Could Open Up Approvals March 1, 2018 Celgene Crashed After Follicular Lymphoma Regimen Failed Phase III December 21, 2017
